Notable Labs
Notable Labs, based in Foster City, CA, specializes in personalized drug discovery for blood cancer, utilizing a Predictive Precision Medicine Platform (PPMP) to test drug combinations on actual cancer cells.
Services
Notable Labs specializes in providing predictive precision medicine services, focusing primarily on personalized drug discovery for blood cancer. The company offers a platform that tests combinations of FDA-approved drugs on an individual’s actual cancer cells. This service is highly relevant for patients with relapsed and refractory cancer, as well as for pharma and biotech partners seeking innovative treatment solutions. Notable Labs currently engages in testing relapsed/refractory cancer patients and also conducts trials and studies in collaboration with pharmaceutical and biotech entities.
Industry and Sub-industry
Notable Labs operates within the healthcare industry, specifically within the diagnostics sub-industry. The company’s work is centered around the utilization of advanced diagnostic techniques and tools to facilitate personalized drug discovery. Their technological focus addresses critical unmet needs in the treatment of cancer, especially in cases where patients have relapsed or have refractory cancer.
Company History and Y-Combinator
Notable Labs was part of the Winter 2015 batch of Y-Combinator, a startup accelerator known for propelling high-growth technology companies. Since then, the company has established itself in Foster City, California, and built a highly automated laboratory. Over the years, Notable Labs has presented research at significant conferences, such as the AACR 2024, showing the efficacy of its Predictive Precision Medicine Platform (PPMP).
Research and Publications
Notable Labs has actively contributed to cancer research, presenting two posters at the AACR 2024 that elaborate on their Predictive Precision Medicine Platform (PPMP). The company has advanced the Volasertib Phase 2 Program through PPMP-guided enrollment and reported that their PPMP accurately predicted the outcome of the Fosciclopirox trial. Additionally, a study published in JCO Precision Oncology demonstrated PPMP’s potential in identifying novel drug combinations in Juvenile Myelomonocytic Leukemia (JMML). These contributions highlight Notable Labs’ role in pioneering predictive precision medicine.
Careers and Employment Opportunities
Notable Labs offers a variety of job openings for professionals in the healthcare and diagnostics field, including positions for Clinical Laboratory Scientists (CLS). The company is committed to providing equal employment opportunities irrespective of race, color, religion, age, sex, national origin, disability status, genetics, veteran status, sexual orientation, gender identity, or expression. This commitment underlines their dedication to maintaining a diverse, inclusive, and equitable workplace.